Longevity.
Author: Michael
Immunis Inc.
A recent study published in Read More
BioXtek CEO Dr Bruce Werber on a new healing par
Thanks to the dedicated efforts of an internatio
SARS-CoV-2, the virus responsible for the COVID-
Company aims to offer at-home clinical trial ser
Pilot study explores low-dose rapamycin’s pote